Cryo Cell International (CCEL) Total Non-Current Liabilities (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Total Non-Current Liabilities data on file, last reported at $79.2 million in Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $79.2 million, up 264.79% year-over-year; the trailing twelve-month figure through Feb 2026 was $79.2 million (up 264.79% YoY), and the FY2025 annual result was $19.8 million, down 74.57% from the prior year.
• Total Non-Current Liabilities rose to $79.2 million in Q1 2026 per CCEL's latest filing, from $19.8 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $79.2 million in Q1 2026 and troughed at $17.4 million in Q3 2024.
• A 5-year average of $45.7 million and a median of $50.0 million in 2022 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities slumped 74.67% in 2024, then surged 347.43% in 2025.
• A 5-year view of Total Non-Current Liabilities shows it stood at $19.5 million in 2022, then gained by 7.1% to $20.9 million in 2023, then jumped by 273.11% to $77.8 million in 2024, then sank by 74.57% to $19.8 million in 2025, then jumped by 300.33% to $79.2 million in 2026.
• Business Quant data shows CCEL's Total Non-Current Liabilities at $79.2 million in Q1 2026, $19.8 million in Q4 2025, and $78.0 million in Q3 2025.